Cognitive Decline Slowed With Cognitive Remediation in At-Risk Adults
By Elana Gotkine HealthDay Reporter
FRIDAY, Nov. 1, 2024 -- For older adults at risk for cognitive decline, especially those with remitted major depressive disorder (rMDD), with or without mild cognitive impairment (MCI), cognitive remediation (CR) plus transcranial direct current stimulation (tDCS) is effective for slowing cognitive decline, according to a study published online Oct. 30 in JAMA Psychiatry.
Tarek K. Rajji, M.D., from the Campbell Family Mental Health Research Institute in Toronto, and colleagues examined the efficacy of CR plus tDCS targeting the prefrontal cortex in older adults with rMDD, MCI, or both. A total of 486 older adults provided consent; 375 received at least one intervention session.
The researchers found that CR and tDCS slowed cognitive decline in older adults with rMDD or MCI during a median follow-up of 48.3 months (adjusted z score difference at month 60, 0.21; 95 percent confidence interval, 0.07 to 0.35). CR and tDCS did not improve cognition acutely in the preplanned primary analysis (adjusted z score difference at month 2, 0.06; 95 percent confidence interval, −0.006 to 0.12). There was a weak and not significant effect seen for CR and tDCS on delaying progression from normal cognition to MCI or from MCI to dementia (hazard ratio, 0.66; 95 percent confidence interval, 0.40 to 1.08). Treatment effects were seen for executive function and verbal memory in preplanned analyses; interactions were seen with diagnosis and APOE ε4, indicating a larger effect for those with rMMD and for APOE ε4 noncarriers.
"Our trial demonstrated the efficacy of a combined therapy of CR and tDCS in slowing cognitive decline in a high-risk sample," the authors write.
Several authors disclosed ties to the biopharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted November 2024
Read this next
Random Forest AI Model Superior for Inpatient Mortality Prognostication in Cirrhosis
THURSDAY, July 24, 2025 -- For inpatients with cirrhosis, a machine learning (ML) model using random forest (RF) analysis is superior for prediction of inpatient mortality...
Inflammation and Nutrition-Based Scores Tied to Prognosis of Low-Risk Myelodysplastic Syndrome
THURSDAY, July 24, 2025 -- The Prognostic Nutritional Index (PNI) and systemic oxidative stress (SOS) score are independently associated with poorer prognosis of low-risk...
Few School Principals Report District-Mandated Mental Health Screening
THURSDAY, July 24, 2025 -- Few school principals report district-mandated mental health screening in schools, according to a study published online July 18 in JAMA Network...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.